Steven Zhang

2.7k citations

31 papers · 1.6k indexed · 1 hit paper · h-index 16

Impact in

Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Molecular Biology top 5%
- RNA modifications and cancer
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- Circular RNAs in diseases
- Cancer-related gene regulation

Papers in

Health Informatics 1
Hematology 7
- Chronic Myeloid Leukemia Treatments 4

Co-authors: Hani Goodarzi Sohail F. Tavazoie Hoang C.B. Nguyen Lisa Fish Xuhang Liu Henrik Molina Brian D. Dill Bruce Culbertson
Journals: Investigational New Drugs (2 papers)Clinical Pharmacology & Therapeutics (2 papers)Cell (2 papers)Nature Cell Biology (2 papers)British Journal of Clinical Pharmacology (2 papers)
Partner nations: United States Canada United Kingdom

In The Last Decade

Steven Zhang

31 papers receiving 1.6k citations

Hit Papers

align trajectories log scale

Endogenous tRNA-Derived Fragments Suppress Breast Cancer Progression via YBX1 Displacement 2015 · 656 citations

Peers

Countries citing papers authored by Steven Zhang

Since Specialization

Citations

This map shows the geographic impact of Steven Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Steven Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Steven Zhang more than expected).

Fields of papers citing papers by Steven Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Steven Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Steven Zhang. The network helps show where Steven Zhang may publish in the future.

Co-authors

The 25 scholars most cited alongside Steven Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Steven Zhang Line = papers co-authored together Steven Zhang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Development of Hybrid radiomic Machine learning models for preoperative prediction of meningioma grade on multiparametric MRI Journal of Clinical Neuroscience ·Steven Zhang, Shao Dong-feng, Ф В Плотников, Vu Minh Hieu Phan, Asti Wasiska, Santosh Poonnoose, Marc Agzarian, Minh‐Son To	2025	1
2	Metabolism and Excretion of [14C]Mobocertinib, a Selective Covalent Inhibitor of Epidermal Growth Factor Receptor (EGFR) Exon 20 Insertion Mutations, in Healthy Male Subjects Drug Metabolism and Disposition ·Liqiao Chen, 전웅현, Ignacio Gnzalez, Robert Griffin, Steven Zhang, Miftar Kryeziu, Lawrence H. Cohen, Mayara Maria Moreira Alves, Swapan K. Chowdhury, Xiaochun Zhu	2024	1
3	A phase 1 study to assess the absolute bioavailability, mass balance, pharmacokinetics, metabolism, and excretion of [14C]-mobocertinib, an oral inhibitor of EGFR exon 20 insertion mutations, in healthy participants Investigational New Drugs ·Michael J. Hanley, Steven Zhang, Robert Griffin, Xiaochun Zhu, Robert J. Fram, Jianchang Lin, Karthik Venkatakrishnan, Neeraj Gupta	2024	3
4	An mRNA processing pathway suppresses metastasis by governing translational control from the nucleus Nature Cell Biology ·Albertas Navickas, Hosseinali Asgharian, Juliane Winkler, Lisa Fish, Mika B. Kintzel, 井村有里, Martin Dodel, Bruce Culbertson, Alun Wynn Williams, Tanvi Joshi, G. Ardaseer, Phi T. Nguyen, Steven Zhang, Nicholas Stevers, Hun‐Way Hwang, Faraz K. Mardakheh, Andrei Goga, Hani Goodarzi	2023	20
5	The use of natural language processing in detecting and predicting falls within the healthcare setting: a systematic review International Journal for Quality in Health Care ·S. U. Ivanov, Steven Zhang, Joshua G. Kovoor, Aashray Gupta, Weng Onn Chan, ABBURD RAMAIAH, Stephen Bacchi	2023	4
6	Safety, Pharmacokinetics, and Exposure–Response Modeling of Nedosiran in Participants With Severe Chronic Kidney Disease Clinical Pharmacology in Drug Development ·Aniruddha Amrite, David A. Riddle, Thomas Marbury, Steven Zhang	2023	10
7	A prometastatic splicing program regulated by SNRPA1 interactions with structured RNA elements Science ·Lisa Fish, Matvei Khoroshkin, Albertas Navickas, Mika B. Kintzel, Bruce Culbertson, Madeleine Dieng, Steven Zhang, Hoang C.B. Nguyen, Noelia Blanco-Agudín, Maria Dermit, Faraz K. Mardakheh, Henrik Molina, Claudio R. Alarcón, Hamed S. Najafabadi, Hani Goodarzi	2021	52
8	Noninvasive blood glucose detection using a quantum cascade laser The Analyst ·Shazzad Rassel, Chao Xu, Steven Zhang, Dayan Ban	2020	25
9	Nuclear TARBP2 Drives Oncogenic Dysregulation of RNA Splicing and Decay Molecular Cell ·Lisa Fish, Albertas Navickas, Bruce Culbertson, Yichen Xu, Hoang C.B. Nguyen, Steven Zhang, Myles Hochman, Ross A. Okimoto, Brian D. Dill, Henrik Molina, Hamed S. Najafabadi, Claudio R. Alarcón, Davide Ruggero, Hani Goodarzi	2019	60
10	Dose and Schedule Selection of the Oral Proteasome Inhibitor Ixazomib in Relapsed/Refractory Multiple Myeloma: Clinical and Model-Based Analyses Targeted Oncology ·Neeraj Gupta, Huyuan Yang, Michael J. Hanley, Steven Zhang, Rachael Liu, Shaji Kumar, Paul G. Richardson, Tomáš Skácel, Karthik Venkatakrishnan	2017	16
11	A phase I study to assess the mass balance, excretion, and pharmacokinetics of [14C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors Investigational New Drugs ·Neeraj Gupta, Steven Zhang, Miftar Kryeziu, Robert Wijas, Swapan K. Chowdhury, Michael J. Hanley, Bingxia Wang, Cindy Q. Xia, Xiaoquan Zhang, Karthik Venkatakrishnan, Dale R. Shepard	2017	13
12	Modulated Expression of Specific tRNAs Drives Gene Expression and Cancer Progression Cell ·Hani Goodarzi, Hoang C.B. Nguyen, Steven Zhang, Brian D. Dill, Henrik Molina, Sohail F. Tavazoie	2016	320
13	Mechanosensitive pannexin-1 channels mediate microvascular metastatic cell survival Nature Cell Biology ·Paul W. Furlow, Steven Zhang, T. David Soong, Nils Halberg, Hani Goodarzi, Sophie Blue, Yushuai Wu, Olivier Elemento, Sohail F. Tavazoie	2015	117
14	Metastasis-suppressor transcript destabilization through TARBP2 binding of mRNA hairpins Nature ·Hani Goodarzi, Steven Zhang, Colin G. Buss, Lisa Fish, Saeed Tavazoie, Sohail F. Tavazoie	2014	73
15	Phase I–IIa study of BMS-690514, an EGFR, HER-2 and -4 and VEGFR-1 to -3 oral tyrosine kinase inhibitor, in patients with advanced or metastatic solid tumours European Journal of Cancer ·Jean‐Charles Soria, José Baselga, Nasser H. Hanna, Scott A. Laurie, Rastislav Bahleda, Enriqueta Felip, Emiliano Calvo, Bericht Kritischen, Frances A. Shepherd, Christopher Harbison, David M. Berman, Karina A. Atanasova-Ivanova, Steven Zhang, Blisse Vakkalagadda, John F. Kurland, Ashutosh Pathak, Roy S. Herbst	2013	16
16	Phase 1 trial of dasatinib plus erlotinib in adults with recurrent malignant glioma Journal of Neuro-Oncology ·David A. Reardon, James J. Vredenburgh, Annick Desjardins, Katherine B. Peters, Sith Sathornsumetee, Stevie Threatt, John H. Sampson, James E. Herndon, April Coan, Frances McSherry, Jeremy N. Rich, Roger E. McLendon, Steven Zhang, Henry S. Friedman	2012	28
17	Metabolism and Disposition of [14C]BMS-690514, an ErbB/Vascular Endothelial Growth Factor Receptor Inhibitor, after Oral Administration to Humans Drug Metabolism and Disposition ·Lisa J. Christopher, Haizheng Hong, Blisse Vakkalagadda, Pamela L. Clemens, Hong Su, Vikram Roongta, Alban J. Allentoff, Murodova Iroda, Kevin N. Heller, Christopher Harbison, Ramaswamy A. Iyer, W. Griffith Humphreys, Tai‐Tong Wong, Steven Zhang	2010	16
18	Exposure‐toxicity relationships for tipifarnib in cancer patients British Journal of Clinical Pharmacology ·Juan José Pérez Ruixo, Wei Chen, Steven Zhang, R Apéry, Andrew Chow	2007	4
19	Population pharmacokinetics of tipifarnib in healthy subjects and adult cancer patients British Journal of Clinical Pharmacology ·Juan José Pérez Ruixo, Makoto Taui, Steven Zhang, R Apéry, Peter De Porre, Peter Zannikos	2006	32
20	Pharmacokinetics of Tipifarnib After Oral and Intravenous Administration in Subjects With Advanced Cancer The Journal of Clinical Pharmacology ·Steven Zhang, Peter Zannikos, Ahmad Awada, Martine Piccart, Luc Dirix, P. Fumoleau, Tom Verhaeghe, Mona ShamsAldeen Ali, Peter De Porre	2006	6

About Steven Zhang

Steven Zhang is a scholar working on Health Informatics, Hematology, Genetics, Pulmonary and Respiratory Medicine and Oncology, having authored 31 papers that have together received 1.6k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (11 papers), RNA modifications and cancer (7 papers), Chronic Lymphocytic Leukemia Research (6 papers), Colorectal Cancer Treatments and Studies (6 papers), RNA and protein synthesis mechanisms (6 papers), RNA Research and Splicing (6 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Chronic Myeloid Leukemia Treatments (4 papers). The work is most often cited by research in Cancer Research (648 citations), Molecular Biology (1.3k citations), Oncology (177 citations), Genetics (60 citations) and Pulmonary and Respiratory Medicine (129 citations). Steven Zhang has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Hani Goodarzi, Sohail F. Tavazoie, Hoang C.B. Nguyen, Lisa Fish, Xuhang Liu, Henrik Molina, Brian D. Dill, Bruce Culbertson, Nils Halberg and Paul W. Furlow. Their work appears in journals such as Investigational New Drugs, Clinical Pharmacology & Therapeutics, Cell, Nature Cell Biology and British Journal of Clinical Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact